United Kingdom · Series D startup
Funding summaryUpdated 26 Oct 2026
$94Mraised across 2 rounds since 2014, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
Cambridge Epigenetix filed 3 raises, $43M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Cambridge Epigenetix's own website: 5 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Cambridge Epigenetix's investors include Sequoia Capital, Google Ventures, Temasek Holdings, New Science Venture and University of Cambridge Enterprise, and 1 more on record.
Cambridge Epigenetix has raised $94M across 2 rounds since 2014.
Cambridge Epigenetix's most recent round was a Series D of $88M in Nov 2021.
Its most recent round, $88M in Nov 2021, is also its largest on record.
Cambridge Epigenetix's first round on record, in Oct 2014, was backed by New Science Venture, University of Cambridge Enterprise and Syncona.
Cambridge Epigenetix's latest named round is a Series D, in Nov 2021.
Cambridge Epigenetix is based in the United Kingdom.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
